About
Daiichi Sankyo appears at No. 749 in the 2026 Global 2000, a multi-factor ranking based on sales, profits, assets and market value. The company is headquartered in Tokyo, Japan and operates primarily in drugs & biotechnology. Reported figures used for the ranking include $14.1B in sales, $1.7B in profit, $25.2B in assets and a market value of $29.5B.